20-64074530-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005873.3(RGS19):c.164G>A(p.Arg55Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000359 in 1,561,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005873.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS19 | ENST00000395042.2 | c.164G>A | p.Arg55Gln | missense_variant | 4/6 | 1 | NM_005873.3 | ENSP00000378483.1 | ||
RGS19 | ENST00000332298.9 | c.164G>A | p.Arg55Gln | missense_variant | 4/6 | 1 | ENSP00000333194.5 | |||
RGS19 | ENST00000493165.1 | n.750G>A | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152212Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000147 AC: 24AN: 163484Hom.: 0 AF XY: 0.000137 AC XY: 12AN XY: 87756
GnomAD4 exome AF: 0.000378 AC: 532AN: 1408966Hom.: 0 Cov.: 34 AF XY: 0.000345 AC XY: 240AN XY: 696266
GnomAD4 genome AF: 0.000184 AC: 28AN: 152212Hom.: 0 Cov.: 34 AF XY: 0.000121 AC XY: 9AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.164G>A (p.R55Q) alteration is located in exon 4 (coding exon 3) of the RGS19 gene. This alteration results from a G to A substitution at nucleotide position 164, causing the arginine (R) at amino acid position 55 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at